195 related articles for article (PubMed ID: 14550821)
1. Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure.
Kovarik JM; Eisen H; Dorent R; Mancini D; Vigano M; Rouilly M; Hsu CH; Rordorf C
J Heart Lung Transplant; 2003 Oct; 22(10):1117-25. PubMed ID: 14550821
[TBL] [Abstract][Full Text] [Related]
2. Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range.
Kovarik JM; Kaplan B; Tedesco Silva H; Kahan BD; Dantal J; Vitko S; Boger R; Rordorf C
Transplantation; 2002 Mar; 73(6):920-5. PubMed ID: 11923693
[TBL] [Abstract][Full Text] [Related]
3. Everolimus therapeutic concentration range defined from a prospective trial with reduced-exposure cyclosporine in de novo kidney transplantation.
Kovarik JM; Tedesco H; Pascual J; Civati G; Bizot MN; Geissler J; Schmidli H
Ther Drug Monit; 2004 Oct; 26(5):499-505. PubMed ID: 15385832
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine.
Kovarik JM; Kahan BD; Kaplan B; Lorber M; Winkler M; Rouilly M; Gerbeau C; Cambon N; Boger R; Rordorf C;
Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038
[TBL] [Abstract][Full Text] [Related]
5. Everolimus in pulmonary transplantation: pharmacokinetics and exposure-response relationships.
Kovarik JM; Snell GI; Valentine V; Aris R; Chan CK; Schmidli H; Pirron U
J Heart Lung Transplant; 2006 Apr; 25(4):440-6. PubMed ID: 16563975
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of an everolimus-cyclosporine immunosuppressive regimen over the first 6 months after kidney transplantation.
Kovarik JM; Kaplan B; Silva HT; Kahan BD; Dantal J; McMahon L; Berthier S; Hsu CH; Rordorf C
Am J Transplant; 2003 May; 3(5):606-13. PubMed ID: 12752317
[TBL] [Abstract][Full Text] [Related]
7. Influence of everolimus on cyclosporine Neoral pharmacokinetics in Chinese de novo cardiac transplant recipients.
Wang CH; Chou NK; Wu FL; Ko WJ; Tsao CI; Chi NH; Hsu RB; Wang SS
Transplant Proc; 2006 Sep; 38(7):2032-4. PubMed ID: 16979990
[TBL] [Abstract][Full Text] [Related]
8. Differential pharmacokinetic interaction of tacrolimus and cyclosporine on everolimus.
Kovarik JM; Curtis JJ; Hricik DE; Pescovitz MD; Scantlebury V; Vasquez A
Transplant Proc; 2006 Dec; 38(10):3456-8. PubMed ID: 17175302
[TBL] [Abstract][Full Text] [Related]
9. Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysis.
Viganò M; Tuzcu M; Benza R; Boissonnat P; Haverich A; Hill J; Laufer G; Love R; Parameshwar J; Pulpón LA; Renlund D; Abeywickrama K; Cretin N; Starling RC; Eisen HJ;
J Heart Lung Transplant; 2007 Jun; 26(6):584-92. PubMed ID: 17543781
[TBL] [Abstract][Full Text] [Related]
10. Everolimus in pediatric de nova renal transplant patients.
Hoyer PF; Ettenger R; Kovarik JM; Webb NJ; Lemire J; Mentser M; Mahan J; Loirat C; Niaudet P; VanDamme-Lombaerts R; Offner G; Wehr S; Moeller V; Mayer H;
Transplantation; 2003 Jun; 75(12):2082-5. PubMed ID: 12829916
[TBL] [Abstract][Full Text] [Related]
11. Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporine.
Shihab FS; Cibrik D; Chan L; Kim YS; Carmellini M; Walker R; Zibari G; Pattison J; Cornu-Artis C; Wang Z; Tedesco-Silva H
Clin Transplant; 2013; 27(2):217-26. PubMed ID: 23230975
[TBL] [Abstract][Full Text] [Related]
12. Influence of delayed initiation of cyclosporine on everolimus pharmacokinetics in de novo renal transplant patients.
Kovarik JM; Dantal J; Civati G; Rizzo G; Rouilly M; Bettoni-Ristic O; Rordorf C
Am J Transplant; 2003 Dec; 3(12):1576-80. PubMed ID: 14629289
[TBL] [Abstract][Full Text] [Related]
13. Review of the proliferation inhibitor everolimus.
Nashan B
Expert Opin Investig Drugs; 2002 Dec; 11(12):1845-57. PubMed ID: 12457444
[TBL] [Abstract][Full Text] [Related]
14. Everolimus: a proliferation signal inhibitor targeting primary causes of allograft dysfunction.
Kovarik JM
Drugs Today (Barc); 2004 Feb; 40(2):101-9. PubMed ID: 15045032
[TBL] [Abstract][Full Text] [Related]
15. Long-term cardiovascular risk in transplantation--insights from the use of everolimus in heart transplantation.
Eisen H
Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii9-13. PubMed ID: 16815858
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring for everolimus in kidney transplantation using 12-month exposure, efficacy, and safety data.
Lorber MI; Ponticelli C; Whelchel J; Mayer HW; Kovarik J; Li Y; Schmidli H
Clin Transplant; 2005 Apr; 19(2):145-52. PubMed ID: 15740547
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of everolimus-facilitated calcineurin inhibitor minimization over 24 months in renal transplantation.
Cibrik D; Silva HT; Vathsala A; Lackova E; Cornu-Artis C; Walker RG; Wang Z; Zibari GB; Shihab F; Kim YS
Transplantation; 2013 Apr; 95(7):933-42. PubMed ID: 23422495
[TBL] [Abstract][Full Text] [Related]
18. Everolimus with reduced cyclosporine versus MMF with standard cyclosporine in de novo heart transplant recipients.
Lehmkuhl HB; Arizon J; Viganò M; Almenar L; Gerosa G; Maccherini M; Varnous S; Musumeci F; Hexham JM; Mange KC; Livi U;
Transplantation; 2009 Jul; 88(1):115-22. PubMed ID: 19584690
[TBL] [Abstract][Full Text] [Related]
19. Late acute cardiac allograft rejection: new therapeutic options?
Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH
Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161
[TBL] [Abstract][Full Text] [Related]
20. Everolimus in combination with cyclosporin a as pre- and posttransplantation immunosuppressive therapy in nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Junghanss C; Rathsack S; Wacke R; Weirich V; Vogel H; Drewelow B; Mueller S; Altmann S; Freund M; Lange S
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1061-8. PubMed ID: 22182476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
